Company Portfolio
Novartis AG
Patents indexed
2
Year range
2010 – 2019
biotechpharmaceutical
Patent Activity by Year
20101
20191
All Patents
2
Career timeline
2 patents, 2010–2019
Dot size = forward citations
Hover or tap any dot to see the patent. Larger dots indicate more forward citations — a proxy for downstream influence.
US 10472419·2019
How Novartis Engineered Antibodies to Block the TIM-3 Immune Checkpoint
A patent describing specific genetic blueprints for antibodies designed to bind to and inhibit the TIM-3 protein, a key target in cancer and immune system research.
US 7740842·2010
How to Keep High-Concentration Antibody Medicines Stable in Liquid Form
Novartis's patent describes a specific liquid recipe for keeping high concentrations of E25 anti-IgE antibodies stable and usable for medical injections.
Patent monitoring